Topchoice Medical (SHSE:600763) Cyclically Adjusted Revenue per Share: ¥5.16 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600763 Topchoice Medical Corp SHSE:600763
91 GF Score
Price ¥37.50
GF Value ¥47.66
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Topchoice Medical Cyclically Adjusted Revenue per Share?

Topchoice Medical SHSE:600763 +1.87% 91 Cyclically Adjusted Revenue per Share is ¥5.16 as of Mar. 2026. GuruFocus rates SHSE:600763 with a GF Score™ of 91/100 and a GF Value™ of ¥47.66 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Topchoice Medical's adjusted revenue per share for the three months ended in Mar. 2026 was ¥1.657. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥5.16 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Topchoice Medical's average Cyclically Adjusted Revenue Growth Rate was 10.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 12.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 15.60% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 21.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Topchoice Medical was 27.70% per year. The lowest was 12.60% per year. And the median was 20.70% per year.

As of today (2026-08-16), Topchoice Medical's current stock price is ¥37.50. Topchoice Medical's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was ¥5.16. Topchoice Medical's Cyclically Adjusted PS Ratio of today is 7.27.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Topchoice Medical was 117.03. The lowest was 6.46. And the median was 24.96.


Topchoice Medical  (SHSE:600763) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Topchoice Medical's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=37.50/5.16
=7.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Topchoice Medical was 117.03. The lowest was 6.46. And the median was 24.96.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Topchoice Medical Cyclically Adjusted Revenue per Share Related Terms


Topchoice Medical Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Topchoice Medical's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Topchoice Medical Cyclically Adjusted Revenue per Share Chart

Topchoice Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.97 3.52 4.03 4.52 5.02

Topchoice Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.66 4.76 4.92 5.02 5.16

SHSE:600763 vs HCA, THC, DVA: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, Topchoice Medical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Topchoice Medical Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Topchoice Medical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Topchoice Medical's Cyclically Adjusted PS Ratio falls into.


SHSE:600763
91GF Score
Topchoice Medical Corp SHSE:600763
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Topchoice Medical Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Topchoice Medical's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.657/116.3033*116.3033
=1.657

Current CPI (Mar. 2026) = 116.3033.

Topchoice Medical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.446 101.400 0.512
201609 0.589 102.400 0.669
201612 0.513 102.600 0.582
201703 0.526 103.200 0.593
201706 0.628 103.100 0.708
201709 0.801 104.100 0.895
201712 0.699 104.500 0.778
201803 0.679 105.300 0.750
201806 0.846 104.900 0.938
201809 1.069 106.600 1.166
201812 0.863 106.500 0.942
201903 0.891 107.700 0.962
201906 0.999 107.700 1.079
201909 1.281 109.800 1.357
201912 1.115 111.200 1.166
202003 0.441 112.300 0.457
202006 1.231 110.400 1.297
202009 1.587 111.700 1.652
202012 1.352 111.500 1.410
202103 1.397 112.662 1.442
202106 1.526 111.769 1.588
202109 1.823 112.215 1.889
202112 1.434 113.108 1.475
202203 1.460 114.335 1.485
202206 1.469 114.558 1.491
202209 1.848 115.339 1.863
202212 1.282 115.116 1.295
202303 1.511 115.116 1.527
202306 1.526 114.558 1.549
202309 1.831 115.339 1.846
202312 1.502 114.781 1.522
202403 1.596 115.227 1.611
202406 1.547 114.781 1.568
202409 1.838 115.785 1.846
202412 1.443 114.893 1.461
202503 1.661 115.116 1.678
202506 1.586 114.907 1.605
202509 1.881 115.471 1.895
202512 1.375 115.832 1.381
202603 1.657 116.303 1.657

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ¥5.16 mean?
Topchoice Medical (SHSE:600763) has a Cyclically Adjusted Revenue per Share of ¥5.16 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Topchoice Medical and its competitors.
Is Topchoice Medical's Cyclically Adjusted Revenue per Share too high?
Topchoice Medical's current Cyclically Adjusted Revenue per Share is ¥5.16. Overall, Topchoice Medical has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Topchoice Medical's Cyclically Adjusted Revenue per Share compare to HCA and THC?
Topchoice Medical's Cyclically Adjusted Revenue per Share of ¥5.16 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Topchoice Medical and its competitors. Topchoice Medical's current Cyclically Adjusted Revenue per Share is ¥5.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Topchoice Medical stock overvalued right now?
Based on GuruFocus' analysis, Topchoice Medical (SHSE:600763) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥47.66, compared to a current price of ¥37.50 — trading 21.3% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ¥5.16. Topchoice Medical's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Topchoice Medical (SHSE:600763), the current Cyclically Adjusted Revenue per Share is ¥5.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Topchoice Medical (SHSE:600763) Overvalued in 2026?

Based on GuruFocus' analysis, Topchoice Medical stock appears to be undervalued. The current stock price of ¥37.50 is trading 21.3% below its estimated GF Value™ of ¥47.66. GuruFocus considers Topchoice Medical to be Modestly Undervalued.

Key valuation signals for SHSE:600763:

  • Cyclically Adjusted Revenue per Share: ¥5.16
  • GF Value™: ¥47.66 vs. price of ¥37.50 (21.3% below fair value)
  • GF Score™: 91/100 with 5 warning signs

No single metric tells the full story. See the SHSE:600763 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Topchoice Medical Business Description

Address No. 21 Lingxi North Road, Building 5, Hesheng International Trade Center, Zhejiang Province, Hangzhou, CHN, 310023
Topchoice Medical Corp is engaged in providing medical services. The company operates as an integrated medical platform with several oral, health, and reproductive medical institutions.
91GF Score

Get the complete analysis for SHSE:600763

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥37.50
Price
¥47.66
GF Value